当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析 - 现金流量表

誉衡药业

(002437)

  

流通市值:66.55亿  总市值:70.76亿
流通股本:20.99亿   总股本:22.32亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,847,160,364.271,211,784,742.07642,222,957.162,752,080,812.82
  收到的税费返还546,693.48546,693.48--
  收到其他与经营活动有关的现金88,834,654.0448,963,812.5615,317,161.65151,052,210.11
  经营活动现金流入小计1,936,541,711.791,261,295,248.11657,540,118.812,903,133,022.93
  购买商品、接受劳务支付的现金278,548,454.92168,639,415.7392,816,118.27416,461,760.19
  支付给职工以及为职工支付的现金250,117,152.68173,650,677.289,686,670.42369,025,953.98
  支付的各项税费170,860,855.27114,206,256.6656,066,320.35255,470,073.01
  支付其他与经营活动有关的现金928,750,388.51649,584,119.99312,496,515.621,451,239,432.64
  经营活动现金流出小计1,628,276,851.381,106,080,469.58551,065,624.662,492,197,219.82
  经营活动产生的现金流量净额308,264,860.41155,214,778.53106,474,494.15410,935,803.11
二、投资活动产生的现金流量:
  收回投资收到的现金933,499,000692,999,000261,499,0006,000,000
  取得投资收益收到的现金34,110,196.664,270,757.25462,086.0411,965,233.33
  处置固定资产、无形资产和其他长期资产收回的现金净额11,405,365.9111,066,705.911,600,00018,731,619.47
  投资活动现金流入小计979,014,562.57708,336,463.16263,561,086.0436,696,852.8
  购建固定资产、无形资产和其他长期资产支付的现金17,581,670.9813,318,605.546,511,825.9662,896,302.76
  投资支付的现金1,290,000,0001,010,000,000370,000,00030,000,000
  取得子公司及其他营业单位支付的现金257,556--2,664,502.38
  投资活动现金流出小计1,307,839,226.981,023,318,605.54376,511,825.9695,560,805.14
  投资活动产生的现金流量净额-328,824,664.41-314,982,142.38-112,950,739.92-58,863,952.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金---103,213,750
  取得借款收到的现金70,000,00070,000,00070,000,000115,000,000
  筹资活动现金流入小计70,000,00070,000,00070,000,000218,213,750
  偿还债务支付的现金---789,860,000
  分配股利、利润或偿付利息支付的现金6,387,591.096,038,757.7668,2509,358,200.27
  其中:子公司支付给少数股东的股利、利润5,621,674.435,621,674.43--
  支付其他与筹资活动有关的现金83,872,599.0682,687,095.582,537,362.772,238,248.06
  筹资活动现金流出小计90,260,190.1588,725,853.2682,605,612.77801,456,448.33
  筹资活动产生的现金流量净额-20,260,190.15-18,725,853.26-12,605,612.77-583,242,698.33
四、汇率变动对现金及现金等价物的影响-968,043.41-266,848.95-90,972.85939,419.49
五、现金及现金等价物净增加额-41,788,037.56-178,760,066.06-19,172,831.39-230,231,428.07
  加:期初现金及现金等价物余额480,772,690.45480,772,690.45480,780,934.88711,004,118.52
  期末现金及现金等价物余额438,984,652.89302,012,624.39461,608,103.49480,772,690.45
补充资料:
  净利润-137,424,012.98-242,540,034.93
  资产减值准备-910,744.9-3,448,945.61
  固定资产和投资性房地产折旧-27,841,117.61-60,791,185.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,841,117.61-60,791,185.49
  无形资产摊销-16,813,986.98-30,490,326.6
  处置固定资产、无形资产和其他长期资产的损失--3,660,243.29--3,395,603.19
  固定资产报废损失-62,680.86-139,571.91
  公允价值变动损失--8,559,844.12-13,979,364.47
  财务费用-824,015.84-8,688,785.12
  投资损失--175,170.34--5,250,989.35
  递延所得税-1,019,439.73-5,711,818.91
  其中:递延所得税资产减少-1,281,690.78-4,545,039.89
    递延所得税负债增加--262,251.05-1,166,779.02
  存货的减少-18,331,603.98--31,043,091.13
  经营性应收项目的减少-9,397,371.65-77,652,956.81
  经营性应付项目的增加--52,777,434.73--17,054,511.32
  其他-7,083,644.12-23,558,155.89
  现金的期末余额-302,012,624.39-480,772,690.45
  减:现金的期初余额-480,772,690.45-711,004,118.52
  现金及现金等价物的净增加额--178,760,066.06--230,231,428.07
公告日期2025-10-292025-08-272025-04-262025-04-26
审计意见(境内)标准无保留意见
TOP↑